Edward K. Maina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Edward K. Maina has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
E.A. Bukusi
Centre for Microbiology Research-Kenya medical Research Institute, P.O Box 54840-00200, Nairobi
3 shared publications- Asma A. Adan
Centre for Microbiology Research-Kenya medical Research Institute, P.O Box 54840-00200, Nairobi, Kenya
2 shared publications M. Lartey
Department of Medicine, School of Medicine & Dentistry, CHS, University of Ghana, Ghana
2 shared publicationsM. Sedegah
Malaria Program, Naval Medical Research Centre, USA
2 shared publications- Raphael Mwamtsi Lwembe
Centre for Virus Research (CVR) Kenya Medical Research Institute (KEMRI) Nairobi Kenya kemri.org
2 shared publications W.K. Ampofo
Department of Virology, Noguchi Memorial Institute for Medical Research, College of Health Sciences (CHS), University of Ghana, Ghana
2 shared publications
Latest Publications
- Open Access
- 10 June 2025
- Published by Springer Nature in Thyroid Research
- Vol. 18 (1) , 1-9
Prevalence of thyroid dysfunction in highly active antiretroviral therapy -Exposed people living with human immunodeficiency virus
The incidence of thyroid dysfunction is high in HIV patients, contributing to the high mortality and morbidity associated with HIV. This study focused on evaluating the prevalence of thyroid dysfunction and associated factors among people living with HIV (PLWH) attending Comprehensive care centre at Maua Methodist Hospital, Kenya. Clinical and sociodemographic data of participants were collected including HIV viral loads, CD4 counts, HAART regimen and type, age, gender, marital and education status, and co-infection. Serum levels of thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3) were assessed in all groups. Regression analysis and Pearson correlation were performed to assess thyroid dysfunction and associated factors. The prevalence of thyroid dysfunction was 51.9% (95% CI: 50.8 ~ 53.2) in this population. 77% (77%) of the HAART group had thyroid dysfunction compared to 47% of the HAART naïve group. Additionally, the prevalence of thyroid dysfunction was high in the HIV-non-suppressed individuals (97%, 95% CI: 97.1 ~ 97.9) compared to suppressed group (83%, 95% CI: 82.7 ~ 84.3). HIV (p < 0.001), HAART exposure (p < 0.001), TB (p < 0.001) and duration of infection (p = 0.002) were significantly associated with thyroid dysfunction. There was a positive correlation between TSH (r = 0.28; p < 0.01) and HIV + individuals under HAART, TSH (r = 0.37; p < 0.001) and TB, and FT3 (r = 0.35; p < 0.001) and duration of infection. Additionally, there was positive corelation between thyroid dysfunction and age (r = 0.13, p = 0.13), and a negative correlation between thyroid dysfunction and CD4 counts (r = -0.39, p < 0.055) though statistically not significant. Thyroid dysfunction is more common in HIV patients on HAART, mainly manifested as subclinical hypothyroidism. Routine screening for thyroid dysfunction should be considered for PLWH, especially those on HAART and with viral blips.
- 10 June 2025
- Published by Springer Nature in Thyroid Research
- Vol. 18 (1) , 1-9
Open AccessPrevalence of thyroid dysfunction in highly active antiretroviral therapy -Exposed people living with human immunodeficiency virus
The incidence of thyroid dysfunction is high in HIV patients, contributing to the high mortality and morbidity associated with HIV. This study focused on evaluating the prevalence of thyroid dysfunction and associated factors among people living with HIV (PLWH) attending Comprehensive care centre at Maua Methodist Hospital, Kenya. Clinical and sociodemographic data of participants were collected including HIV viral loads, CD4 counts, HAART regimen and type, age, gender, marital and education status, and co-infection. Serum levels of thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3) were assessed in all groups. Regression analysis and Pearson correlation were performed to assess thyroid dysfunction and associated factors. The prevalence of thyroid dysfunction was 51.9% (95% CI: 50.8 ~ 53.2) in this population. 77% (77%) of the HAART group had thyroid dysfunction compared to 47% of the HAART naïve group. Additionally, the prevalence of thyroid dysfunction was high in the HIV-non-suppressed individuals (97%, 95% CI: 97.1 ~ 97.9) compared to suppressed group (83%, 95% CI: 82.7 ~ 84.3). HIV (p < 0.001), HAART exposure (p < 0.001), TB (p < 0.001) and duration of infection (p = 0.002) were significantly associated with thyroid dysfunction. There was a positive correlation between TSH (r = 0.28; p < 0.01) and HIV + individuals under HAART, TSH (r = 0.37; p < 0.001) and TB, and FT3 (r = 0.35; p < 0.001) and duration of infection. Additionally, there was positive corelation between thyroid dysfunction and age (r = 0.13, p = 0.13), and a negative correlation between thyroid dysfunction and CD4 counts (r = -0.39, p < 0.055) though statistically not significant. Thyroid dysfunction is more common in HIV patients on HAART, mainly manifested as subclinical hypothyroidism. Routine screening for thyroid dysfunction should be considered for PLWH, especially those on HAART and with viral blips.
- Open Access
- 18 November 2022
- Published by Springer Nature in Research Square
Analysis of Phytochemical Composition and Antioxidant Activities of Aqueous and Methanol Extracts of Black, Green, Purple, and White Teas Grown in Kenya
Background Tea, a widely consumed beverage worldwide increasingly elicits interest due to reported high levels of polyphenols. Polyphenols have been extensively investigated, as they are a potential source of natural antioxidants. Methods The aim of the study was to determine and compare the phytochemical composition and antioxidant activities of aqueous and methanol extracts of black, green, purple, and white teas found in selected regions of Kenya.A total of 56 samples were obtained from tea classified as black, green,purple, and white tea in various factories. The samples were then grounded and extracted using methanol and de-ionized water for 48 hours. The composition of phenolic and tannin contents was determined using Folin- Ciocalteu method. Flavonoids content was determined through the formation of the flavonoids– aluminum complex assay. Antioxidant activity was determined through the DPPH scavenging activity and the iron-reducing power of the extracts. Results The phenolic contents in all samples were significantly higher than flavonoid and tannin levels. In samples extracted with water, the phenolic contents were high (41.74 ± 5.25) mg/g, while flavonoid (0.58 ± 0.06 mg/g) and tannin levels (2.47 ± 0.79) mg/g were relatively low. There was a negative correlation between phytochemicals and the antioxidant activity of the various teas. Conclusions The findings suggest that the different teas have high levels of phytochemicals and are natural antioxidants, however there is no significant variation at p = 0.05 in the composition of phytochemical compounds among the different tea groups.
- 18 November 2022
- Published by Springer Nature in Research Square
Open AccessAnalysis of Phytochemical Composition and Antioxidant Activities of Aqueous and Methanol Extracts of Black, Green, Purple, and White Teas Grown in Kenya
Background Tea, a widely consumed beverage worldwide increasingly elicits interest due to reported high levels of polyphenols. Polyphenols have been extensively investigated, as they are a potential source of natural antioxidants. Methods The aim of the study was to determine and compare the phytochemical composition and antioxidant activities of aqueous and methanol extracts of black, green, purple, and white teas found in selected regions of Kenya.A total of 56 samples were obtained from tea classified as black, green,purple, and white tea in various factories. The samples were then grounded and extracted using methanol and de-ionized water for 48 hours. The composition of phenolic and tannin contents was determined using Folin- Ciocalteu method. Flavonoids content was determined through the formation of the flavonoids– aluminum complex assay. Antioxidant activity was determined through the DPPH scavenging activity and the iron-reducing power of the extracts. Results The phenolic contents in all samples were significantly higher than flavonoid and tannin levels. In samples extracted with water, the phenolic contents were high (41.74 ± 5.25) mg/g, while flavonoid (0.58 ± 0.06 mg/g) and tannin levels (2.47 ± 0.79) mg/g were relatively low. There was a negative correlation between phytochemicals and the antioxidant activity of the various teas. Conclusions The findings suggest that the different teas have high levels of phytochemicals and are natural antioxidants, however there is no significant variation at p = 0.05 in the composition of phytochemical compounds among the different tea groups.
- Open Access
- 26 January 2021
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 19 (1) , 14-26
A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure
Background: During the past 35 years, highly effective ART has saved the lives of millions of people worldwide by suppressing viruses to undetectable levels. However, this does not translate to the absence of viruses in the body as HIV persists in latent reservoirs. Indeed, rebounded HIV has been recently observed in the Mississippi and California infants previously thought to have been cured. Hence, much remains to be learned about HIV latency, and the search for the best strategy to eliminate the reservoir is the direction current research is taking. A systems-level approach that fully recapitulates the dynamics and complexity of HIV-1 latency In vivo and is applicable in human therapy is prudent for HIV eradication to be more feasible. Objectives: The main barriers preventing the cure of HIV with antiretroviral therapy have been identified, progress has been made in the understanding of the therapeutic targets to which potentially eradicating drugs could be directed, integrative strategies have been proposed, and clinical trials with various alternatives are underway. The aim of this review is to provide an update on the main advances in HIV eradication, with particular emphasis on the obstacles and the different strategies proposed. The core challenges of each strategy are highlighted and the most promising strategy and new research avenues in HIV eradication strategies are proposed. Methods: A systematic literature search of all English-language articles published between 2015 and 2019, was conducted using MEDLINE (PubMed) and Google scholar. Where available, medical subject headings (MeSH) were used as search terms and included: HIV, HIV latency, HIV reservoir, latency reactivation, and HIV cure. Additional search terms consisted of suppression, persistence, establishment, generation, and formation. A total of 250 articles were found using the above search terms. Out of these, 89 relevant articles related to HIV-1 latency establishment and eradication strategies were collected and reviewed, with no limitation of study design. Additional studies (commonly referenced and/or older and more recent articles of significance) were selected from bibliographies and references listed in the primary resources. Results : In general, when exploring the literature, there are four main strategies heavily researched that provide promising strategies to the elimination of latent HIV: Haematopoietic Stem-Cell Transplantation, Shock and Kill Strategy, Gene-specific transcriptional activation using RNA-guided CRISPR-Cas9 system, and Block and Lock strategy. Most of the studies of these strategies are applicable in vitro, leaving many questions about the extent to which, or if any, these strategies are applicable to complex picture In vivo. However, the success of these strategies at least shows, in part, that HIV-1 can be cured, though some strategies are too invasive and expensive to become a standard of care for all HIV-infected patients. Conclusion: Recent advances hold promise for the ultimate cure of HIV infection. A systems-level approach that fully recapitulates the dynamics and complexity of HIV-1 latency In vivo and applicable in human therapy is prudent for HIV eradication to be more feasible. Future studies aimed at achieving a prolonged HIV remission state are more likely to be successful if they focus on a combination strategy, including the block and kill, and stem cell approaches. These strategies propose a functional cure with minimal toxicity for patients. It is believed that the cure of HIV infection will be attained in the short term if a strategy based on purging the reservoirs is complemented with an aggressive HAART strategy.
- 26 January 2021
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 19 (1) , 14-26
Open AccessA Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure
Background: During the past 35 years, highly effective ART has saved the lives of millions of people worldwide by suppressing viruses to undetectable levels. However, this does not translate to the absence of viruses in the body as HIV persists in latent reservoirs. Indeed, rebounded HIV has been recently observed in the Mississippi and California infants previously thought to have been cured. Hence, much remains to be learned about HIV latency, and the search for the best strategy to eliminate the reservoir is the direction current research is taking. A systems-level approach that fully recapitulates the dynamics and complexity of HIV-1 latency In vivo and is applicable in human therapy is prudent for HIV eradication to be more feasible. Objectives: The main barriers preventing the cure of HIV with antiretroviral therapy have been identified, progress has been made in the understanding of the therapeutic targets to which potentially eradicating drugs could be directed, integrative strategies have been proposed, and clinical trials with various alternatives are underway. The aim of this review is to provide an update on the main advances in HIV eradication, with particular emphasis on the obstacles and the different strategies proposed. The core challenges of each strategy are highlighted and the most promising strategy and new research avenues in HIV eradication strategies are proposed. Methods: A systematic literature search of all English-language articles published between 2015 and 2019, was conducted using MEDLINE (PubMed) and Google scholar. Where available, medical subject headings (MeSH) were used as search terms and included: HIV, HIV latency, HIV reservoir, latency reactivation, and HIV cure. Additional search terms consisted of suppression, persistence, establishment, generation, and formation. A total of 250 articles were found using the above search terms. Out of these, 89 relevant articles related to HIV-1 latency establishment and eradication strategies were collected and reviewed, with no limitation of study design. Additional studies (commonly referenced and/or older and more recent articles of significance) were selected from bibliographies and references listed in the primary resources. Results : In general, when exploring the literature, there are four main strategies heavily researched that provide promising strategies to the elimination of latent HIV: Haematopoietic Stem-Cell Transplantation, Shock and Kill Strategy, Gene-specific transcriptional activation using RNA-guided CRISPR-Cas9 system, and Block and Lock strategy. Most of the studies of these strategies are applicable in vitro, leaving many questions about the extent to which, or if any, these strategies are applicable to complex picture In vivo. However, the success of these strategies at least shows, in part, that HIV-1 can be cured, though some strategies are too invasive and expensive to become a standard of care for all HIV-infected patients. Conclusion: Recent advances hold promise for the ultimate cure of HIV infection. A systems-level approach that fully recapitulates the dynamics and complexity of HIV-1 latency In vivo and applicable in human therapy is prudent for HIV eradication to be more feasible. Future studies aimed at achieving a prolonged HIV remission state are more likely to be successful if they focus on a combination strategy, including the block and kill, and stem cell approaches. These strategies propose a functional cure with minimal toxicity for patients. It is believed that the cure of HIV infection will be attained in the short term if a strategy based on purging the reservoirs is complemented with an aggressive HAART strategy.
- Open Access
- 1 August 2020
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 97, 151-158
Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya
- 1 August 2020
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 97, 151-158
Open AccessIncidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya
- 1 December 2015
- Published by Elsevier in Immunology Letters
- Vol. 168 (2) , 279-284
CD4+ T cell counts in initiation of antiretroviral therapy in HIV infected asymptomatic individuals; controversies and inconsistencies
- 1 December 2015
- Published by Elsevier in Immunology Letters
- Vol. 168 (2) , 279-284
CD4+ T cell counts in initiation of antiretroviral therapy in HIV infected asymptomatic individuals; controversies and inconsistencies